Results

Total Results: 1,259 records

Showing results for "reason".

121. Cell-Free-Dna-Appendix-C-Prepub-Final (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-appendix-c-prepub-final.xlsx
     January 01, 2025 - 1.1 Reason 1.2 Did any funders with conflicts of interest have an important involvement in the trial? … 1.2 Reason 1.3 How sufficient was the information that concern about conflicts of interest of funders … 1.3 Reason 2.1 Did any of the primary academic researchers have important conflicts of interest? … 2.1 Reason 2.2 How sufficient was the information that concern about conflicts of interest of primary … 1.3 Reason 2.1 Did any of the primary academic researchers have important conflicts of interest?

122. Cell-Free-Dna-Final-App-C (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-final-app-c.xlsx
     January 01, 2025 - 1.1 Reason 1.2 Did any funders with conflicts of interest have an important involvement in the trial? … 1.2 Reason 1.3 How sufficient was the information that concern about conflicts of interest of funders … 1.3 Reason 2.1 Did any of the primary academic researchers have important conflicts of interest? … 2.1 Reason 2.2 How sufficient was the information that concern about conflicts of interest of primary … 1.3 Reason 2.1 Did any of the primary academic researchers have important conflicts of interest?

123. PATIENTSLIKEME (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/clifford.pdf
     May 29, 2025 - PATIENTSLIKEME INNOVATIONS CONFERENCE -- PATIENTSLIKEME SPEAKER: DAVE CLIFFORD, HEAD OF PUBLIC HEALTH AND GOVERNMENT AFFAIRS, PATIENTSLIKEME CLIFFORD: Hi. I'm Dave Clifford from PatientsLikeMe. I'm gonna talk about patient value in online communities a bit from our experie…

124. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_disposition-comments.pdf
     March 10, 2010 - Then "I^2 > 50%" is not appropriately used here for another reason as it is calculated based on the … The reason that they are the same is because events (e.g. … The reason that they are the same is because events (e.g. all-cause mortality) was reported to have … However, only for a very obvious identified reason would we exclude outliers and rerun a particular … For this reason, we have standard procedures to ensure that double blinding is maintained, allocation

125. Renal Artery Stenosis Management Strategies: An Updated Comparative Effectiveness Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-update_disposition-comments.pdf
     August 16, 2016 - outcomes and fewer CV events, it might be helpful to provide some discussion about the postulated reason … outcomes and fewer CV events, it might be helpful to provide some discussion about the postulated reason

126. Disposition of Comments for Progestogens for Prevention of Preterm Birth (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth-disposition-121205.pdf
     September 07, 2012 - provide meta-estimates for these outcomes as reduction of infant morbidity and mortality is the major reason … This is the reason why the efficacy of 17-alpha hydroxyprogesterone caproate is questionable. … This is the reason why another randomized clinical trial is now in progress to test the efficacy and

127. Disposition of Comments_Comparative Effectiveness Review No. 253: Maternal and Child Outcomes Associated With the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/maternal-child-outcomes-wic-disposition-comments.pdf
     April 19, 2022 - To clarify, the primary reason was no comparison group or does not address the association of WIC

128. Computerized Definitions Showed High Positive Predictive Values for Identifying Reasons for Hospitalizations in a Medicaid Population with Rheumatoid Arthritis | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/rheumatoid-arthritis-hospitalizations/research

129. Disposition of Comments for CER 175 Total Worker Health (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/worker-health_disposition-comments.pdf
     May 31, 2016 - The reason this should NOT be an inclusion criterion is that multifactorial diseases by definition … summary to remove the short section title “implications for employers and policy-makers” for this reason

130. Evidence-based Practice Center Systematic Review Protocol - Management of Infantile Epilepsies (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-252-infantile-epilepsies-disposition-comments.pdf
     October 25, 2022 - evidence on some older medications and surgical procedures was likely omitted from the report for this reason … evidence on some older medications and surgical procedures was likely omitted from the report for this reason … evidence on some older medications and surgical procedures was likely omitted from the report for this reason

131. Breast-Cancer-Imaging Technical-Brief (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-imaging_technical-brief.pdf
     October 01, 2014 - • Patients can also experience anxiety about imaging so that’s a reason to limit tests, but on the … List of Excluded Published Literature Studies Number Citation Reason for Exclusion 1 Agarwal … Number Citation Reason … Number Citation Reason … Number Citation Reason

132. Thompson_ECCS2012 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/thompson_eccs2012.pdf
     January 01, 2012 - were  viewed  as  inevitable,  participants   speculated  that there  would  be  no reason

133. Ch 11-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_11-user-guide-to-ocer_130129.pdf
     January 03, 2012 - resemble that of the “nonusers”; if not, there is a possibility that confounding by indication is the reason … Graphical Presentation One reason to use graphical methods is that the variable being modeled is itself … Another reason for a graphical display is to present the conditions that a confounder would need to

134. Disposition of Comments Report for Biologic and Nonbiologic Systemic Agents and Phottherapy for Treatment of Chronic Plaque Psoriasis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_disposition-comments.pdf
     November 27, 2012 - For this reason, it is also important to capture long-term safety to obtain a global aspect of how … The reason for exclusion, which corresponds to the reasons in Figure 1, is listed in Table 1 and 2 … The first row of each section of excluded studies provide the reason why that section of studies was

135. Disposition of Comments Report for Local Hepatic Therapies for Metastases to the Liver From Unresectable Colorectal Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-liver-metastases-therapies_disposition-comments.pdf
     December 11, 2012 - sponsorship to acknowledge; hence the absence of such is not an omission from the paper -- an inappropriate reason

136. Fagerlin-notes-151007 copy-Teresa (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/fagerlin-presentation.pdf
     May 29, 2025 - Fagerlin-notes-151007 copy-Teresa When  we talk about patient engagement and  shared  decision-­‐making there are a number of different problems that evolve. 1 First, patients often do not have information they need to make decisions, nor are they involved in the  decisions as much  as they would  …

137. Disposition of Comments for Evidence Report #208 Part 5 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/public-reporting-quality-improvement_disposition-comments.pdf
     July 26, 2012 - It stands to reason, then, that the patient/consumer should also be identified as a final outcome target … 2) Line 23-34: ‘one reason..’ is unclear how volume and market share is associated with consumer choice … There may be a reason for separating these studies, but if so, it needs to be made clearer. … For this reason the authors do not want to include opinions in the report that are not linked to literature … We agree that measures used for any reason, including public reporting, should match the purpose for

138. Decision Modeling (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-decision-modeling.ppt
     June 01, 2012 - Decision Modeling Deciding Whether To Complement a Systematic Review of Medical Tests With Decision Modeling Prepared for: The Agency for Healthcare Research and Quality (AHRQ) Training Modules for Medical Test Reviews Methods Guide www.ahrq.gov Deciding Whether To Complement a Systematic Review of Medical Tests W…

139. Decision Modeling (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-decision-modeling.ppt
     June 01, 2012 - Decision Modeling Deciding Whether To Complement a Systematic Review of Medical Tests With Decision Modeling Prepared for: The Agency for Healthcare Research and Quality (AHRQ) Training Modules for Medical Test Reviews Methods Guide www.ahrq.gov Deciding Whether To Complement a Systematic Review of Medical Tests W…

140. Disposition of Comments for Pulmonary Arterial Hypertension: Screening, Management, and Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_disposition-comments.pdf
     April 25, 2013 - their hospitalization outcome, but it appears that many studies reported hospitalization for any reason … I believe the reason that there is only one prospective study, is that clinical experience has already … I believe the reason that there is only one prospective study, is that clinical experience has already … list of excluded studies in Appendix E in alphabetical order by first author, accompanied by the reason … RCTs for epoprostenol) seems foolish unless there is a very good reason to do so.